Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host?s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.
The Live Cell Encapsulation industry can be broken down into several segments, Alginate, HEMA-MMA, etc.
Across the world, the major players cover BioTime, Reed Pacific, Viacyte, etc.
This report contains market size and forecasts of Live Cell Encapsulation in Global, including the following market information:
Global Live Cell Encapsulation Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Live Cell Encapsulation market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Alginate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Live Cell Encapsulation include Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc. and Altucell, Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Live Cell Encapsulation companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Live Cell Encapsulation Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Live Cell Encapsulation Market Segment Percentages, by Type, 2021 (%)
Alginate
Chitosan
Cellulose
Others
Global Live Cell Encapsulation Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Live Cell Encapsulation Market Segment Percentages, by Application, 2021 (%)
Diabetes
Cancer
Epilepsy
Parkinson
Others
Global Live Cell Encapsulation Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Live Cell Encapsulation Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Live Cell Encapsulation revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Live Cell Encapsulation revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Viacyte, Inc.
Living Cell Technologies Ltd.
Sigilon Therapeutics, Inc
Sernova Corporation
PharmaCyte Biotech Inc
Gloriana Therapeutics
Kadimastem
Beta-O2 Technologies, Inc.
Altucell, Inc.
Diatranz Otsuka Ltd

LEAVE A REPLY

Please enter your comment!
Please enter your name here